Monday, December 23, 2024
HomeTagsReata Pharmaceuticals

Reata Pharmaceuticals

Reata Pharmaceuticals Completes Rolling Submission of New Drug Application for Omaveloxolone for the Treatment of Patients with Friedreich’s Ataxia

Reata Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company, announced the completion of the rolling submission of a New Drug Application (“NDA”) to the U.S. Food...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics